Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminia Massarelli

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|May 31, 2025
Treating <i>KRAS G12C</i> lung cancer: therapeutic potential of investigation drugs in early clinical studyKendra Wilson, Jesus Salvador Flores Banda, Fatima Raza, et al.
Bioanalysis|August 16, 2023
An LC-MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasmaYe Feng, Erminia Massarelli, Eric Forman, et al.
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
Translational Cancer Research|February 4, 2022
Narrative review of immunotherapy and radiation therapy in elderly patientsBrittney Chau, Jonnby LaGuardia, Caressa Hui, et al.
Cancer|September 24, 2004
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderlyCesare Gridelli, Erminia Massarelli, Paolo Maione, et al.
Clinical Lung Cancer|August 13, 2024
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung CancerAmanda Reyes, Michelle Afkhami, Erminia Massarelli, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomasXiming Tang, Marileila Varella-Garcia, Ana C Xavier, et al.
Oncotarget|March 16, 2018
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patientsSagus Sampath, Haejung Won, Erminia Massarelli, et al.
Head & Neck|May 31, 2024
The impact of pretreatment symptom burden on long-term quality of life following head and neck radiation: A prospective longitudinal studyColton Ladbury, Taylor Wilde, Arya Amini, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|May 31, 2025
Treating <i>KRAS G12C</i> lung cancer: therapeutic potential of investigation drugs in early clinical studyKendra Wilson, Jesus Salvador Flores Banda, Fatima Raza, et al.
Bioanalysis|August 16, 2023
An LC-MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasmaYe Feng, Erminia Massarelli, Eric Forman, et al.
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
Translational Cancer Research|February 4, 2022
Narrative review of immunotherapy and radiation therapy in elderly patientsBrittney Chau, Jonnby LaGuardia, Caressa Hui, et al.
Cancer|September 24, 2004
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderlyCesare Gridelli, Erminia Massarelli, Paolo Maione, et al.
Clinical Lung Cancer|August 13, 2024
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung CancerAmanda Reyes, Michelle Afkhami, Erminia Massarelli, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomasXiming Tang, Marileila Varella-Garcia, Ana C Xavier, et al.
Oncotarget|March 16, 2018
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patientsSagus Sampath, Haejung Won, Erminia Massarelli, et al.
Head & Neck|May 31, 2024
The impact of pretreatment symptom burden on long-term quality of life following head and neck radiation: A prospective longitudinal studyColton Ladbury, Taylor Wilde, Arya Amini, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Pageof 12